- Home
- ZVSA vs JFBR Comparison
ZVSA vs JFBR Comparison
Compare ZVSA & JFBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- JFBR
- Stock Information
- Founded
- ZVSA 2014
- JFBR 2017
- Country
- ZVSA United States
- JFBR Israel
- Employees
- ZVSA N/A
- JFBR N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- JFBR Other Specialty Stores
- Sector
- ZVSA Health Care
- JFBR Consumer Discretionary
- Exchange
- ZVSA Nasdaq
- JFBR Nasdaq
- Market Cap
- ZVSA 2.5M
- JFBR 4.8M
- IPO Year
- ZVSA N/A
- JFBR 2022
- Fundamental
- Price
- ZVSA $1.49
- JFBR $2.42
- Analyst Decision
- ZVSA Strong Buy
- JFBR
- Analyst Count
- ZVSA 1
- JFBR 0
- Target Price
- ZVSA $240.00
- JFBR N/A
- AVG Volume (30 Days)
- ZVSA 2.1M
- JFBR 403.9K
- Earning Date
- ZVSA 11-14-2024
- JFBR 09-30-2024
- Dividend Yield
- ZVSA N/A
- JFBR N/A
- EPS Growth
- ZVSA N/A
- JFBR N/A
- EPS
- ZVSA N/A
- JFBR N/A
- Revenue
- ZVSA N/A
- JFBR $12,335,000.00
- Revenue This Year
- ZVSA N/A
- JFBR N/A
- Revenue Next Year
- ZVSA N/A
- JFBR N/A
- P/E Ratio
- ZVSA N/A
- JFBR N/A
- Revenue Growth
- ZVSA N/A
- JFBR 66.98
- 52 Week Low
- ZVSA $0.98
- JFBR $0.17
- 52 Week High
- ZVSA $25.00
- JFBR $3.96
- Technical
- Relative Strength Index (RSI)
- ZVSA 61.69
- JFBR 49.21
- Support Level
- ZVSA $1.25
- JFBR $2.36
- Resistance Level
- ZVSA $1.95
- JFBR $2.89
- Average True Range (ATR)
- ZVSA 0.17
- JFBR 0.25
- MACD
- ZVSA 0.05
- JFBR -0.06
- Stochastic Oscillator
- ZVSA 51.58
- JFBR 17.91
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About JFBR Jeffs' Brands Ltd
Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.